Symptoms of Heart Failure (NYHA Class II-III)
1 clinical trials · Condition
◉ Watch Symptoms of Heart Failure (NYHA Class II-III)
| Record | Firm | Date |
|---|---|---|
| Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP) (NCT01900600) | Virginia Commonwealth University | 2013-04-01 |
Track Symptoms of Heart Failure (NYHA Class II-III) automatically
Every clearance here is in the API, with alerts when new ones post.